Anti-diabetic drugs and weight loss in patients with type 2 diabetes.
Pharmacol Res
; 171: 105782, 2021 09.
Article
en En
| MEDLINE
| ID: mdl-34302978
Palabras clave
Acarbose (PubChem CID: 41774); Anti-diabetic drugs; Body composition; Canagliflozin (PubChem CID: 24812758); Dapagliflozin (PubChem CID: 9887712); Diabesity; Empagliflozin (PubChem CID: 11949646); Ertugliflozin (PubChem CID: 44814423); Exenatide (PubChem CID: 45588096); Liraglutide (PubChem CID: 16134956); Metformin (PubChem CID: 4091); Semaglutide (PubChem CID: 56843331); Type 2 diabetes; Weight loss
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Pérdida de Peso
/
Diabetes Mellitus Tipo 2
/
Hipoglucemiantes
/
Obesidad
Tipo de estudio:
Risk_factors_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article